Highest-materiality recent filing
Aemetis Q2 revenue $62.7M (+20% YoY); net loss narrows to $9.4M from $23.4M
Revenue of $62.7M, up 20% YoY, including $8.6M of Section 45Z production tax credits.
Aemetis Q1 revenue up 27% to $54.6M; gross profit turns positive; RNG volumes up 55%
Revenue $54.6M (+27% YoY); gross profit $2.8M vs gross loss $5.1M in Q1 2025
Aemetis Q4 2025 net loss narrows to $5.3M; biogas net income $12.2M, dairy RNG up 61% YoY
Q4 2025 revenue + PTCs $53.7M, up from $47.0M YoY; full-year $208.0M vs $268M (lower ethanol/India biodiesel).
Aemetis shareholders approve increase in authorized common stock; preferred stock decrease fails
Shareholders approved amendment to increase authorized common stock from 80M to 140M shares at Feb 18, 2026 special meeting.
Redemption deadline moved from Dec 31, 2025 to Apr 30, 2026; price set at $114.7M including a $2M fee.
Aemetis authorizes $80M stock buyback; approves executive bonuses and $350K CEO guarantee fee
Board authorized up to $80M share repurchase of common stock; open market or private; no expiration date.
Aemetis Q3 2025 revenue $59.2M, net loss $23.7M; MVR system contract signed
Revenue $59.2M, up $7M from Q2 2025, driven by India OMC orders and stronger ethanol.
Aemetis extends biogas unit's $118.8M preferred unit redemption deadline; faces 16%+ credit if unmet
ABGL extends redemption of Protair-X's Series A Preferred Units from Aug 31, 2025 to Dec 31, 2025.
Aemetis Q2 2025 revenue $52.2M, net loss $23.4M; India subsidiary IPO targeted early 2026
Revenue $52.2M, up $9.3M from Q1 2025; gross loss $3.4M vs $1.8M loss a year ago.
Aemetis Q1 revenue falls 41% to $42.9M; net loss $24.5M; India biodiesel LOIs $31M
Revenue of $42.9M vs $72.6M YoY, driven by India OMC contract delays; Keyes ethanol plant revenue up $1.7M on higher prices.
Aemetis FY2024 revenue $268M (+43% YoY); net loss more than doubles to $87.5M
Annual revenues grew 43% to $268M driven by all segments: ethanol +55%, India biodiesel +20%, biogas +139%.
Aemetis extends maturity of $136M in notes one year to April 2026 via written notice
Subsidiaries notified Third Eye Capital to extend maturity from Apr 1, 2025 to Apr 1, 2026.
Aemetis (AMTX) amends ATM agreement to sell up to $210M in common stock
Aemetis may sell up to $210M of common stock through an at-the-market offering via H.C. Wainwright at market prices.
Aemetis Q3 2024 revenues up 19% YoY to $81.4M; net loss widens to $17.9M
Net loss of $17.9M vs net income of $30.7M in Q3 2023; operating loss improved to $3.9M from $8.5M.
Aemetis Q2 2024 revenue up 48% to $66.6M; net loss widens to $29.2M
Q2 2024 revenue $66.6M (+48% YoY): California Ethanol $40.1M, India Biodiesel $28.8M, Dairy RNG $1.6M from 89,400 MMBtu.
Aemetis reports Q1 revenue $72.6M, up from $2.2M; net loss $24.2M vs $26.4M
Revenue $72.6M (Q1 2023: $2.2M) driven by Keyes plant restart and dairy RNG + India biodiesel.
Aemetis reports 2023 revenue $186.7M, net loss $46.4M; India biodiesel sales up 175%
Q4 revenue $70.8M (up from $66.7M YoY); net loss $25.4M vs $22.4M prior year.
Aemetis projects $1.95B revenue and $645M adjusted EBITDA by 2028 in updated Five Year Plan
Revenue projected at $1.95B in 2028 with 38% CAGR; adjusted EBITDA of $645M at 83% CAGR.
Aemetis extends $117.2M in notes with Third Eye Capital by one year to April 2025
Subsidiaries exercised extension right, pushing maturity of $117.2M in notes from April 1, 2024 to April 1, 2025.
Aemetis Biogas extends preferred unit redemption to Apr 30, 2024; $111M credit facility possible
Redemption deadline extended from Dec 31, 2023 to Apr 30, 2024; price increased to $111M.
Aemetis Q3 2023 net income $30.7M on $63M IRA tax credit sale; debt repayment $50.2M
Revenue $68.7M; net income $30.7M ($0.79 diluted EPS) includes $55.2M cash from sale of IRA investment tax credits.
Aemetis reports Q3 net income $30.7M on $55.2M IRA tax credit sale; revenue down 4%
Basic EPS $0.79 vs ($1.78) loss in Q3 2022; includes $55.2M cash from IRA tax credits.
Aemetis Biogas closes $53M sale of IRA investment tax credits; expects $800M more
Sold $53M of Section 48 investment tax credits to an unrelated corporate purchaser on Sept 29, 2023.
Aemetis Q2 revenue $45.1M vs $65.9M YoY; net loss widens to $25.3M
Revenue of $45.1M, down 31.6% YoY; India Biodiesel contributed $33.6M, Keyes ethanol restarted in late May.
Aemetis Biogas closes $25M USDA-guaranteed loan to fund digesters for eight additional dairies
Loan of $25M at 8.75% fixed for 5 years, 20-year term from Magnolia Bank, guaranteed by USDA.
Aemetis Biogas extends Series A preferred redemption to Aug 31, 2023; $132.5M final price
ABGL waives non-compliance with covenants; redemption deadline moved from May 31 to Aug 31, 2023.
Aemetis subsidiary amends procurement agreement, issues warrants to restart Keyes ethanol plant
Aemetis Keyes to pay Heiskell equivalent of 4 days grain over 120 days or by Sep 30, 2023, as restart working capital repayment.
Aemetis Q1 revenue collapses to $2.2M from $52M; net loss widens to $26.4M
Revenue fell 96% to $2.2M as Keyes ethanol plant idled from Dec 2022 through Q1 due to high natural gas prices.
Aemetis FY2022 revenue up 21% to $257M but net loss widens to $107.8M
Revenue $257M (+21% YoY); Q4 revenue $66.7M vs $64.4M.
Missed Dec 31, 2022 redemption of $116M Series A Preferred Units; waiver and amendment executed Feb 6, 2023.
Aemetis Q3 revenue up 44% to $71.8M; net loss $69.8M includes $53.9M redemption charge
Revenue $71.8M (+44% YoY); ethanol sales 15.7M gal; India biodiesel $11M in ~2 weeks.
Aemetis closes $25M USDA-backed financing for dairy biogas digesters and pipeline
$25M construction loan from Greater Nevada Credit Union; 5.95% interest, matures March 2023.
Aemetis Q2 revenue $65.9M (+20% YoY); net loss narrows to $209K vs $10.6M
Revenue $65.9M vs $54.9M Q2 2021; ethanol price $3.13/gal vs $2.78/gal.
Aemetis board retains director Barton after majority withhold vote at annual meeting
Director Francis P. Barton received 9,834,135 withheld votes vs 5,619,798 for votes at May 26 meeting.
Aemetis Q4 revenue $64.4M, net loss narrows to $881K; FY revenue $212M, net loss $47.1M
Q4 2021 revenue $64.4M vs $37.3M YoY; gross profit $12.7M vs gross loss $3.4M.
Aemetis closes $100M credit facilities with Third Eye Capital; repays $16M higher-rate debt
New $100M aggregate facilities: $50M at 8% for carbon reduction projects, $50M at 10% for working capital.
Aemetis, Inc. (the “Company”) has appointed J. Michael Rockett as Executive Vice President, General Counsel, and Corporate Secretary, effective as of August 28, 2023.
On October 14, 2021, the Company’s Board of Directors (the “Board”) increased the number of directors and appointed Timothy Simon as a Class II director to fill the newly available directorship
Max materiality 0.85 · Median 0.70 · Most common event earnings